A Phase 1b Dose Range Finding Study of Phenserine Compared to Donepezil in Participants With Early or Mild Alzheimer's Disease
Latest Information Update: 17 Jan 2025
Price :
$35 *
At a glance
- Drugs Donepezil (Primary) ; Phenserine (Primary)
- Indications Alzheimer's disease
- Focus Biomarker; Pharmacodynamics
- Acronyms PATH-1
- Sponsors Helse Stavanger HF
- 17 Jan 2025 New trial record